Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

On the mechanism of impaired insulin secretion in chronic renal failure.
G Z Fadda, … , L G Lipson, S G Massry
G Z Fadda, … , L G Lipson, S G Massry
Published January 1, 1991
Citation Information: J Clin Invest. 1991;87(1):255-261. https://doi.org/10.1172/JCI114979.
View: Text | PDF
Research Article

On the mechanism of impaired insulin secretion in chronic renal failure.

  • Text
  • PDF
Abstract

It has been suggested that a sustained rise in resting levels of cytosolic calcium [Ca2+]i of pancreatic islets is responsible for impaired insulin secretion in chronic renal failure (CRF). Evidence for such an event is lacking and the mechanisms through which it may affect insulin secretion are not known. Studies were conducted in normal, CRF, and normocalcemic, parathyroidectomized (PTX) CRF rats to answer these questions. Resting levels of [Ca2+]i of islets from CRF rats were higher (P less than 0.01) than in control of CRF-PTX rats. [3H]2-deoxyglucose uptake and cAMP production by islets were not different in the three groups. Insulin content of, and glucose-induced insulin secretion by islets from CRF rats was lower (P less than 0.01) than in control and CRF-PTX rats. In contrast, glyceraldehyde-induced insulin release by CRF islets was normal. Basal ATP content, both glucose-stimulated ATP content and ATP/ADP ratio, net lactic acid output, Vmax of phosphofructokinase-1, and Ca2+ ATPase of islets from CRF rats were lower (P less than 0.02-less than 0.01) than in normal or CRF-PTX animals. Data show that: (a) Glucose but not glyceraldehyde-induced insulin secretion is impaired in CRF; (b) the impairment in glucose-induced insulin release in CRF is due to a defect in the metabolism of glucose; (c) this latter defect is due to reduced ATP content induced partly by high [Ca2+]i of islets; and (d) the high [Ca2+]i in islets of CRF rats is due to augmented PTH-induced calcium entry into cells and decreased calcium extrusion from the islets secondary to reduced activity of the Ca2+ ATPase.

Authors

G Z Fadda, S M Hajjar, A F Perna, X J Zhou, L G Lipson, S G Massry

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2013 2011 2010 2009 2008 2006 2003 2002 2001 1999 1998 1997 1996 1995 1994 1993 1992 1991 1979 Total
Citations: 1 1 1 1 2 1 2 2 1 5 1 1 3 1 2 2 2 4 2 1 3 5 1 5 2 4 1 57
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (57)

Title and authors Publication Year
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
Rhee CM, Kalantar-Zadeh K, Tuttle KR
Current Opinion in Nephrology and Hypertension 2022
Extracellular Inorganic Phosphate-Induced Release of Reactive Oxygen Species: Roles in Physiological Processes and Disease Development
MA Lacerda-Abreu, JR Meyer-Fernandes
International journal of molecular sciences 2021
When ESKD complicates the management of diabetes mellitus
JH William, A Morales, SE Rosas
Seminars in Dialysis 2020
Disturbances in Insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes
MN Rahhal, NE Gharaibeh, L Rahimi, F Ismail-Beigi
The Journal of clinical endocrinology and metabolism 2019
Vascular toxicity of urea, a new “old player” in the pathogenesis of chronic renal failure induced cardiovascular diseases
I Giardino, M DApolito, M Brownlee, AB Maffione, AL Colia, M Sacco, P Ferrara, M Pettoello-Mantovani
TURK PEDIATR ARSIVI 2018
Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins
L Koppe, D Fouque, CO Soulage
Current Diabetes Reports 2018
Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus
Y Xie, B Bowe, T Li, H Xian, Y Yan, Z Al-Aly
Kidney International 2017
Urea impairs β-cell glycolysis and insulin secretion in chronic kidney disease
Laetitia Koppe, Elsa Nyam, Kevin Vivot, Jocelyn Manning Fox, Xiao-Qing Dai, Bich Nguyen, Dominique Trudel, Attané Camille, Valentine Moullé, Patrick MacDonald, Julien Ghislain, Vincent Poitout
Journal of Clinical Investigation 2016
Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model
SD Rodenbeck, CA Zarse, ML McKenney-Drake, RS Bruning, M Sturek, NX Chen, SM Moe
Nephrology Dialysis Transplantation 2016
Update on Glycemic Control for the Treatment of Diabetic Kidney Disease
GN Nadkarni, R Yacoub, SG Coca
Current Diabetes Reports 2015
Mitochondrial oxidative stress mediates high-phosphate-induced secretory defects and apoptosis in insulin-secreting cells
TT Nguyen, X Quan, KH Hwang, S Xu, R Das, SK Choi, A Wiederkehr, CB Wollheim, SK Cha, KS Park
American journal of physiology. Endocrinology and metabolism 2015
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen
Nutritional Management of Renal Disease 2013
Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
A Lishmanov, S Dorairajan, Y Pak, K Chaudhary, A Chockalingam
International Urology and Nephrology 2011
Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients
E Tatar, MS Demirci, F Kircelli, O Gungor, MN Turan, ES Ok, G Asci, M Ozkahya, E Ok
International Urology and Nephrology 2011
Sequence of Cellular Events in Pancreatic Islets Leading to Impaired Insulin Secretion in Chronic Kidney Disease
SG Massry
Journal of Renal Nutrition 2011
Predicting hospital cost in CKD patients through blood chemistry values
RW Bessette, RL Carter
BMC Nephrology 2011
Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets
H You, SG Laychock
American journal of physiology. Endocrinology and metabolism 2011
ACTIVATION OF CASPASE-3 IN THE SKELETAL MUSCLE DURING HEMODIALYSIS
MA Boivin, SI Battah, EA Dominic, K Kalantar-Zadeh, A Ferrando, AH Tzamaloukas, R Dwivedi, TA Ma, P Moseley, DS Raj
European Journal of Clinical Investigation 2010
Management of Acute Kidney Problems
A Jörres, C Ronco, JA Kellum
2009
Modern Nutrition
K LaPoint, M McIntosh
Handbook of Nutrition in the Aged, Fourth Edition 2008
Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure
C Sampanis
Hippokratia 2008
Cinacalcet: pharmacological and clinical aspects
P Messa, C Alfieri, B Brezzi
Expert Opinion on Drug Metabolism & Toxicology 2008
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
N Nagano
Pharmacology & Therapeutics 2006
Derangement of glucose metabolism in hyperparathyroidism
M Procopio, G Borretta
Journal of Endocrinological Investigation 2003
Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors
H Ogata, E Ritz, G Odoni, K Amann, SR Orth
Journal of the American Society of Nephrology : JASN 2003
Intracellular free calcium in the neutrophils of maintenance haemodialysis patients
AM Koorts, MC Kruger, CD Potgieter, M Viljoen
Clinical Physiology and Functional Imaging 2002
Calcium in Internal Medicine
H Morii, Y Nishizawa, SG Massry
2002
Insulin secretion in uremia
SG Massry
American Journal of Kidney Diseases 2001
Lipid Metabolism and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Role of Factors Modulating Cytosolic Calcium
MF Gadallah, M El-Shahawy, G Andrews, C Torres-Rivera, D Hanna, M Blatt, M Ibrahim, A Morkos, M Abbassian, M Cooper
Hemodialysis International 2001
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
SG Rostand, TB Drueke
Kidney International 1999
Erythrocyte voltage-dependent calcium influx is reduced in hemodialyzed patients
L Soldati, D Adamo, S Zerbi, A Caumo, R Spaventa, G Bianchi, G Vezzoli
Kidney International 1999
Distribution of the Parathyroid Hormone 2 Receptor in Rat: Immunolocalization Reveals Expression by Several Endocrine Cells*
TB Usdin, J Hilton, T Vertesi, G Harta, G Segre, E Mezey
Endocrinology 1999
Elevated Myocardial Cytosolic Calcium Impairs Insulin-Like Growth Factor-1-Stimulated Protein Synthesis in Chronic Renal Failure
DA Qing, HU Ding, J Vadgama, YY Wu, JD Kopple
Journal of the American Society of Nephrology : JASN 1999
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
D Fliser, G Pacini, R Engelleiter, A Kautzky-Willer, R Prager, E Franek, E Ritz
Kidney International 1998
Critical Care Nephrology
C Ronco, R Bellomo
1998
Effects of excess PTH on nonclassical target organs
S Bro, K Olgaard
American Journal of Kidney Diseases 1997
Dysregulation of melatonin metabolism in chronic renal insufficiency: Role of erythropoietin-deficiency anemia
ND Vaziri, F Oveisi, GA Reyes, XJ Jhou
Kidney International 1996
Membrane protein damage and methylation reactions in chronic renal failure
AF Perna, D Ingrosso, P Galletti, V Zappia, NG de Santo
Kidney International 1996
Benefits of Calcitriol Therapy and Serum Phosphorus Control in Dogs and Cats with Chronic Renal Failure
LA Nagode, DJ Chew, M Podell
Veterinary Clinics of North America Small Animal Practice 1996
Impaired agonist-induced calcium signaling in hepatocytes from chronic renal failure rats
SG Massry, M Klin, Z Ni, J Tian, L Kedes, M Smogorzewski
Kidney International 1995
Middle Molecules: Toxicity and Removal by Hemodialysis and Related Strategies
R Vanholder, R Smet, P Vogeleere, S Ringoir
Artificial Organs 1995
Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy
M Akmal, RR Barndt, AN Ansari, JG Mohler, SG Massry
Kidney International 1995
Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients
WH Hörl, M Haag-Weber, B Mai, SG Massry
Kidney International 1995
Elevated cytosolic calcium of adipocytes in chronic renal failure
Z Ni, M Smogorzewski, SG Massry
Kidney International 1995
Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF
YB Zhang, M Smogorzewski, Z Ni, SG Massry
Kidney International 1994
Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine
AF Pema, D Ingrosso, V Zappia, P Galletti, G Capasso, NG de Santo
Journal of Clinical Investigation 1993
Treatment and prevention of hyperkalemia in end-stage renal disease
M Allon
Kidney International 1993
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia
M Allon, A Takeshian, N Shanklin
Kidney International 1993
Chronic Renal Failure is a State of Cellular Calcium Toxicity
SG Massry, GZ Fadda
American Journal of Kidney Diseases 1993
Verapamil Prevents Chronic Renal Failure-Induced Abnormalities in Lipid Metabolism
M Akmal, S Perkins, SE Kasim, HY Oh, M Smogorzewski, SG Massry
American Journal of Kidney Diseases 1993
Decreased O2 consumption by PMNL from humans and rats with CRF: Role of secondary hyperparathyroidism
M Kiersztejn, M Smogorzewski, P Thanakitcharu, GZ Fadda, SG Massry
Kidney International 1992
Cardiac Dysfunction in Chronic Uremia
PS Parfrey, JD Harnett
1992
Impaired insulin secretion of aging: Role of renal failure and hyperparathyroidism
SG Massry, GZ Fadda, XJ Zhou, P Chandrasoma, L Cheng, CR Filburn
Kidney International 1991
Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure
Z Gaciong, JM Alexiewicz, M Linker-Israeli, IA Shulman, TO Pitts, SG Massry
Kidney International 1991
Impaired potassium-induced insulin secretion in chronic renal failure
GZ Fadda, P Thanakitcharu, R Comunale, LG Lipson, SG Massry
Kidney International 1991
Impaired in vivo antibody production in CRF rats: Role of secondary hyperparathyroidism
Z Gaciong, JM Alexiewicz, SG Massry
Kidney International 1991
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher
1979

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts